The content on this site is intended for healthcare professionals only
"We strongly advise elderly patients to participate in studies," Dr Wildiers tells ecancertv at SIOG 2014.
He discusses elder-specific trials of adjuvant chemotherapy in breast cancer and notes the unique challenges of treating HER-2 metastatic breast cancer in the elderly.
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
Updates on HR-positive HER2-negative breast cancer
Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Neo-adjuvant therapy for different cancers in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
The role of lymph nodes in stage 3 lung cancer
